Sponsor or institution
Clinical trials and research at Mapi Pharma Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Mapi Pharma Ltd. that are recruiting, at sites in 2 countries (most in Israel (2), India (1)). By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Semaglutide Depot in Type 2 Diabetes: Safety, Tolerability, and How It Works
This study tests a long-acting form of semaglutide given every four weeks to adults with type 2 diabetes to see if it is safe and helps control blood sugar and weight.
-
Monthly subcutaneous long-acting cariprazine injection for adults with schizophrenia, bipolar I disorder, or major depressive disorder.
This will test a once-a-month subcutaneous long-acting form of cariprazine for adults with schizophrenia, bipolar I disorder, or major depressive disorder who are eligible for the oral medication.
Quick answers
How many clinical trials run by Mapi Pharma Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Israel (2 trials), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.